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Background: The cell and tissue structural properties assessed with a conventional bright-field light microscope
play a key role in cancer diagnosis, but they sometimes have limited accuracy in detecting early-stage cancers or
predicting future risk of cancer progression for individual patients (i.e., prognosis) if no frank cancer is found. The
recent development in optical microscopy techniques now permit the nanoscale structural imaging and quantitative
structural analysis of tissue and cells, which offers a new opportunity to investigate the structural properties of cell
and tissue below 200 – 250 nm as an early sign of carcinogenesis, prior to the presence of microscale morphological
abnormalities. Identification of nanoscale structural signatures is significant for earlier and more accurate cancer
detection and prognosis.
Results: Our group has recently developed two simple spectral-domain optical microscopy techniques for assessing 3D
nanoscale structural alterations – spectral-encoding of spatial frequency microscopy and spatial-domain low-coherence
quantitative phase microscopy. These two techniques use the scattered light from biological cells and tissue and share a
common experimental approach of assessing the Fourier space by various wavelengths to quantify the 3D structural
information of the scattering object at the nanoscale sensitivity with a simple reflectance-mode light microscopy setup
without the need for high-NA optics. This review paper discusses the physical principles and validation of these two
techniques to interrogate nanoscale structural properties, as well as the use of these methods to probe nanoscale
nuclear architectural alterations during carcinogenesis in cancer cell lines and well-annotated human tissue during
carcinogenesis.
Conclusions: The analysis of nanoscale structural characteristics has shown promise in detecting cancer before the
microscopically visible changes become evident and proof-of-concept studies have shown its feasibility as an earlier or
more sensitive marker for cancer detection or diagnosis. Further biophysical investigation of specific 3D nanoscale structural
characteristics in carcinogenesis, especially with well-annotated human cells and tissue, is much needed in cancer research.Background
Cancer develops through a series of genetic and epigenetic
events that ultimately result in structural changes in the
cell nucleus. As such, the structural abnormality of the cell
nucleus (also known as nuclear morphology) is one of
the hallmarks in cancer and remains the gold standard
for cancer diagnosis and prognosis. Due to the diffrac-
tion-limited resolution (~250-500 nm) of conventional
light microscopy, the characteristic morphological changes* Correspondence: liuy@pitt.edu
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unless otherwise stated.identified in cancerous or precancerous cells are limited
to mostly micron-scale features, such as increased nuclear
size, irregular nuclear shape and coarse chromatin texture.
Many structural abnormalities observable at the micro-
scale do not occur until an advanced stage, making it
difficult to distinguish early-stage cancers from benign
conditions. Further, in the era of personalized medicine,
the detection of pre-cancer or early-stage cancer is not
sufficient. As many pre-cancers or early-stage cancers will
never progress into invasive cancer, such detection in fact
may lead to unnecessary treatment in the absence of ag-
gressive cancer that does more harm than good to the pa-
tient at a high cost. Therefore, it is crucial to not only
identify pre-cancer or early-stage cancer, but also predict
which pre-cancer or early-stage cancer is likely to developThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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tional microscale nuclear morphology has some prognos-
tic value, but its accuracy is somewhat limited in many
clinical scenarios.
On the other hand, the nanoscale structural properties,
also referred to as “nano-morphology”, show the potential
to become a new class of morphological markers for earl-
ier and more accurate cancer diagnosis and prognosis. It
is well recognized that cancer is a complex disease involv-
ing early changes in the genome and epigenome [1]. The
nucleus, as the storehouse of the genomic information, is
not a homogeneous organelle with randomly organized
DNA; instead, the DNAs are packed at various densities
and spatially arranged in a certain manner in a 3D space
that is associated with nuclear function [2-4]. Recent stud-
ies using super-resolution microscopy also confirm that
histone octamers are not randomly distributed throughout
the nucleus and that pronounced differences are seen in
the compaction of chromatin with such fluctuation in his-
tone density [5]. The spatial organization of specific chro-
matin domains with a size in the hundred nanometer
range also plays an essential role for gene regulation [4].
During carcinogenesis, the 3D spatial arrangement of
chromatin patterns experience translocation and alter-
ations in the spatial density of chromatin at different loci
of the nucleus. For example, the large-scale changes in 3D
genomic architecture or the changes in spatial distribution
of chromosome have been reported in cancer [6,7]. There-
fore, we hypothesize that the complex genomic and epige-
nomic changes in carcinogenesis result in nanoscale
structural alterations arising from the changes in the 3D
spatial arrangement and the chromatin density variation
in the cell nucleus. In other words, investigating the nano-
morphology characteristics as the downstream structural
manifestation of complex genetic and epigenetic events
regardless of which molecular pathways are involved in
carcinogenesis is an important effort. As such physical
characteristics can be detected easily with low-cost, high
throughput and high sensitivity, yet independent of mo-
lecular heterogeneity, they have the potential to become a
new class of cancer markers to make a significant clinical
impact. For example, the analysis of cellular disorder
strength has been reported to detect nano-architectural
changes early in carcinogenesis that precede microscopic-
ally detectable cytological abnormalities [8] and show the
ability to detect cancer from normal cells from a remote
location in lung, colon and pancreas [9-11].
Elucidation of 3D nano-morphological changes in can-
cer requires tools that are able to interrogate nano-
structures in the cell nucleus and other sub-cellular
components. Thanks to the remarkable advances in
optical microscopy techniques in recent years, the ad-
vanced light microscope now supports the detection of
structural properties at a scale about an order ofmagnitude less than what conventional light microscope
can detect. The nanoscale structural characteristics can
be measured either using direct imaging with nanoscale
resolution, or indirect analysis of optical signals from
light-cell interaction. The direct nanoscopic imaging
can be achieved by super-resolution fluorescence mi-
croscopy techniques, such as stochastic optical recon-
struction microscopy (STORM) [12], photoactivatable
localization microscopy (PALM) [13], stimulated emis-
sion depletion microscopy (STED) [14] and 3D struc-
tured illumination microscopy (3D-SIM) [15]. These
super-resolution microscopy techniques have the ability
to directly image the nanoscale architecture of any la-
beled molecular component in live and fixed cells and
even tissue at a spatial resolution down to 20–50 nm.
The label-free nanoscopic imaging of biological cells at a
resolution of 90 nm based on optical diffraction tomog-
raphy has also been reported recently [16]. A few investi-
gators have pioneered the investigation of 3D nanoscopic
imaging of nuclear architecture in cancer cells [5,17]. As
the super-resolution fluorescence microscopy becomes
commercially available, it will play an essential role in
elucidating how nanoscale structural arrangement in the
nucleus is altered during carcinogenesis. While these are
powerful basic research tools, the clinical translation of
these techniques has several challenges to overcome. Due
to the complex fluorescent staining process, high cost,
sophisticated instrument operation and the very low
throughput, they are not well suited as a routine clinical
diagnostic tool at the current form.
An alternative to direct nanoscopic imaging is indirect
measurement of nanoscale structural properties by prob-
ing optical properties via scattered light. Although it
often does not directly visualize the structures at nano-
scale resolution [as is the case of super-resolution im-
aging], the structural properties from a single cell or
sub-cellular organelle can be indirectly quantified with
nanoscale sensitivity and accuracy by light-scattering
based microscopy techniques. Light scattering is an in-
trinsic optical signal caused by the spatial variation of
intra-cellular macromolecular densities. This approach
has the advantages of simple sample preparation (no mo-
lecular staining or labeling required), simple instrument
and operation, low cost, high throughput and high sensi-
tivity. Such advantages are crucial in translating these
techniques into a real clinical setting to improve cancer
diagnosis and prognosis.
A wide variety of light-scattering microscopy techniques
have been developed to analyze the nano-morphology
characteristics, and can be generalized into the following
four categories based on the underlying physical principles
to achieve nanoscale structural assessment. Please note
that these are broad categories that are not mutually ex-
clusive, and in fact, can and do have overlap. The first
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difference using interferometry-based approach, such as
various versions of quantitative phase microscopy and
digital holographic microscopy (DHM) [18]. The light
interference effect is well known to detect changes in op-
tical path length even at sub-nanometer sensitivity. The
second form is based on the analysis of Fourier space (or
K-space, the conjugate of an object) of scattered light,
such as optical scatter imaging [19] and spectral-encoding
of spatial frequency (SESF) [20-22]. This approach is
based on the concept that any scattering object’s structure
can be described either by the spatial distribution of re-
fractive index or its Fourier components in the far-field
[23]. Although the image resolution is still limited by dif-
fraction, the 2D or 3D structural characteristics of a scat-
tering object can be quantified with a nanoscale precision
by directly assessing the spatial frequencies in K-space.
The third form is to combine microscopic imaging with
light scattering spectroscopy. In this case, the scattered
light is collected as a function of scattering wavelength or/
and angle. Assuming the scattering object as a spherical
or spheroid shape, the structural parameters such as size
distribution from a well-defined microscopic region are
derived from a model-based interpretation (e.g., Mie-
theory, T-matrix). For example, in confocal light absorp-
tion and scattering spectroscopic microscopy [24], the
smallest scatterer is about 100 nm [25]. The fourth form
is referred to as partial-wave spectroscopy that character-
izes the statistical properties of refractive index fluctuation
by disorder strength [8] which is proportional to the amp-
litude and the length scale of the macromolecular density
variations at the scale of ~20 nm.
In this paper, we will focus on reviewing the use of two
spectral-domain optical microscopy techniques – spatial-
domain low-coherence quantitative phase microscopy
(SL-QPM) and spectral-encoding of spatial frequency
(SESF) microscopy – from the first two-categories to in-
terrogate the nanoscale structural information. First, we
review the general theory behind SL-QPM and SESF mi-
croscopy and why the nanoscale structural alterations can
be interrogated. Next, we discuss the technical implemen-
tation and how these techniques are designed to analyze
the human cell and tissue samples. In the third section, we
present the results of how nanoscale nuclear architecture
is altered during carcinogenesis in cancer cell lines and
well-annotated human tissue at different stages of cancer.
Methods
The SL-QPM and SESF microscopy are two optical mi-
croscopy systems that are able to assess the 3D nanoscale
structural information with just simple reflection-mode
optical microscopy setup, without high-NA immersion
objectives or demanding nano-positioning mechanical
scanning, well-suited for low-cost and high throughputclinical use. They share a common theory of light scatter-
ing by an inhomogeneous scattering object and first Born
approximation [23]. It does not assume any a priori infor-
mation about the scattering object (e.g., shape, size) and
the only assumption is that the scattering object is a
weakly scattering object with relative refractive index be-
tween the scattering object and surrounding medium is
close to 1, which can be broadly applied to live or fixed
biological cells and tissue with easy sample preparation.
Both methods also share a common experimental ap-
proach of assessing the Fourier space (i.e., K-space) by
various wavelengths to quantify the structural information
of the scattering object, which can be easily implemented
with tunable light source or spectral device. Further, both
techniques are capable of assessing 3D nanoscale struc-
tural information without the need for axial scanning.
General theory of light scattering by an inhomogeneous
object
Consider a scalar plane wave incident on the scattering
object described by
Ei r; k; tð Þ ¼ A kð Þei kir−ωtð Þ ð1Þ
The 3D structure of the scattering object can be de-
scribed using 3D scattering potential [23] as
F rð Þ ¼ k2 n2 rð Þ−1 = 4πð Þ ð2Þ
where k is the wavenumber and n is the free-space re-
fractive index and r is the location within the scattering
object. Assuming that the plane-wave is incident at an il-
lumination angle θ (θ = 0, as shown in Figure 1a) and
under the first Born approximation [23] (Figure 1b)
which applies to weakly scattering object (i.e., relative re-
fractive index between the scattering object and sur-
rounding medium is close to 1), the scattering amplitude
in the far field is expressed as
f s ki; ksð Þ ¼ ∫
V r0ð Þ
F r0ð Þei ks−kið Þ•r0d3r0 ð3Þ
The Fourier transform of the scattering potential in K-
space is expressed by
~F Kð Þ ¼ ∫F r0ð Þe−iK•r0d3r0 ð4Þ
where the K-space vector is defined as
K ¼ ks−ki ð5Þ
Thus, the scattering amplitude in Eq. (3) turns into
f s ki; ksð Þ ¼ ~F Kð Þ ¼ ~F k s−s0ð Þð Þ ð6Þ
Therefore, the scattering amplitude of the scattering
object under first Born approximation depends only on
(a) (b) (c)
Figure 1 Representation of the scattering vectors in K-space in the reflection configuration. (a) Illustration of the light interaction with the
scattering object, where α is the backscattering angle, and Φ is the azimuthal angle. (b) Representation of the scattering vector for a single
wavelength in K-space (spatial-frequency space), where ki is the incident wave vector and ks is the scattered wave vector. (c) Representation of
scattering vectors in K-space with different wavelengths (from 400 to 700 nm).
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of the scattering potential [23,26].
The Fourier components of the 3D scattering potential
in K-space (or spatial frequency space) can be repre-
sented as an Ewald’s sphere [23]. The light collection nu-
merical aperture (NA) limits the accessible Fourier
components or spatial frequency ranges of the scattering
object, which are represented as the Ewald’s sphere cap
(Figure 1b). When multiple wavelengths are used, a suc-
cession of Ewald’s sphere caps is obtained that define a
muffin-shaped region of spatial frequency support in K-
space for reflection geometry (Figure 1c). Every point on
the Ewald’s sphere corresponds to a specific 3D spatial-
frequency vector:
K ¼ kxxþ kyy þ kzz ð7Þ
where
kx ¼ 2πn sin α− sin θð Þ cos ϕ=λ ð8Þ
ky ¼ 2πn sin α− sin θð Þ sin ϕ=λ ð9Þ
(or kx and ky can be collectively expressed as the lat-
eral spatial frequency
kr ¼ 2πn sin α− sin θð Þ=λ ð10ÞÞ
and
kz ¼ 2πn cos θ þ cos αð Þ=λ ð11Þ
(θ: incident angle; α: scattering angle; φ: azimuthal angle;
λ: wavelength, n: refractive index). These equations canalternatively be expressed by the corresponding spatial pe-
riods defined as
Hx ¼ 2πkx ;Hy ¼
2π
ky
;Hz ¼ 2πkz ð12Þ
If the complex amplitudes of all of the possible 3D
Fourier components (or spatial frequencies) are collected,
the 3D scattering object (scattering potential) can be re-
constructed via 3D inverse Fourier transform, which
serves as the basis for optical diffraction tomography
[23,27]. However, the 3D structure in the reconstructed
scattering object still has the diffraction-limited resolution
due to the NA-limited accessible bandwidth of Fourier
components and integration process of Fourier transform.
A recent advance overcame this limitation by expanding
the collected spatial frequencies of the scattering object
using a high-NA oil immersion objective together with a
deconvolution algorithm to achieve a resolution of 90 nm
[16] in the reconstructed 3D scattering object.
Alternatively, based on the above theory, the nanoscale
structural characteristics of the 3D scattering object can
also be interrogated via two simple light microscopy sys-
tems using a moderate NA (NA ≤ 0.5): Fourier-filtering
based SESF and a spectral interferometry based SL-QPM.
These approaches do not directly image the scattering ob-
ject at the nanoscale resolution, but quantify the nanoscale
structural information by employing the spectral informa-
tion of scattered light from the 3D scattering object. These
approaches can be implemented with simple optical setup
and are widely applicable to live or fixed biological cells,
as well as clinically prepared fixed tissue.
Spectral-encoding of Spatial Frequency (SESF)
General description of SESF
Spectral-encoding of spatial frequency (SESF) is a simple
way to quantify the nanoscale structure of a 3D scattering
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structure-characterizing axial spatial frequency [20,21].
According to the Fourier theory of image formation, the
structural components of a complex object can be quanti-
fied by a distribution of spatial frequencies in the Fourier
space, describing its various spatial scales from large (i.e.,
low spatial frequency) to small (i.e., high spatial fre-
quency). Thus, each pixel in the microscopic image is rep-
resented by a distribution of spectral colors characteristic
of the corresponding axial structure at that image point.
The 3D axial structure at each pixel can thus be quan-
tified at nanoscale accuracy with a simple reflection-
configuration optical microscope setup. It also provides
a unique structure-color based image contrast and
real-time structural characterization.
The theoretical basis of SESF can be easily understood
in the context of Ewald’s sphere. As shown in the
Ewald’s sphere cap (Figure 2a), we note that, for a reflec-
tion configuration with a normal illumination angle
(θ =0°) and moderate light collection NA (e.g., NA ≤ 0.5),
the spatial frequency along the axial (z) direction kz
(or spatial period Hz) at a given wavelength is only
weakly dependent on the backscattering angles or kr
(Figure 2b). We can assume each axial spatial frequency
of the image point can be encoded with a given wave-
length, regardless of what is the backscattering angle
within a moderate collection NA, as illustrated in
Figure 2c. By measuring the intensity distribution as a
function of wavelength for each pixel of the microscopic
image directly on the image plane using a spectral device,
the axial spatial frequency (or spatial-period) profile of a
3D structure at each image point can be reconstructed
with Eq. (11). Alternatively, the dominant axial structure
(one dominant value of spatial period) at each image point
can be visualized as a corresponding color in real time.
Furthermore, if the complex amplitude of the back-
scattered light in the Fourier space can be collected,
when applying the SESF principle, the simultaneous recon-
struction of 3D tomographic image and the quantitative(a) (b)
Figure 2 The correspondence between axial spatial frequency and wa
a normal incidence in the reflection configuration. (b) The axial spatial freq
lateral spatial frequency (kr). (c) Each axial spatial frequency (kz) can be enc
red dashed lines on Figure (b).characterization of 3D structural information at the nano-
scale accuracy from any volume of interest within the 3D
object can also be realized [22].
Nanoscale accuracy
A key advantage of SESF is its nanoscale accuracy in de-
termining the axial spatial period of the structure at each
image point. As discussed above, each axial spatial fre-
quency of the image point can be encoded with a given
wavelength with a small uncertainty. The theoretical uncer-
tainty for determining the axial spatial period (ΔHz) can
be estimated by the following equation
ΔHz ¼ λ 1− cos αð Þ=n 1þ cos θð Þ cos θ þ cos αð Þ
ð13Þ
For example, for a normal incidence (θ = 0°) and the
light collection NA of 0.5 (α = 30°), the estimated uncer-
tainty for axial spatial period is ΔHz = 20 nm with the
corresponding maximum possible error of ±10 nm. A
smaller NA results in a smaller error, however, there is
an inherent trade-off between the image resolution and
the accuracy in axial structural characterization.
A numerical experiment was performed to validate the
nanoscale accuracy of SESF approach. A 3D model ob-
ject was constructed, composed of three known mixed-
sized nanosphere aggregates. Each nanosphere aggregate
unit consists of 10 by 10 by 10 nanospheres with diam-
eter d (d =240 nm, 200 nm and 150 nm, respectively)
(Figure 3a). The spatial period of each nanosphere aggre-
gate unit is defined by [d sin(π/3) + 10] nm in the nu-
merical model, corresponding to the axial spatial period
of 218, 183 and 140 nm, respectively. A plane wave with
spectral range of 400–700 nm at Δλ =10 nm is used.
The backscattered waves for each wavelength, within the
collected NA (NA = 0.5), are generated with the Born
approximation [23]. In the averaged axial spatial-period
profile (Figure 3b), the peak of three nano-structural
units (219, 183 and 149 nm) are within the theoretical(c)
velength in the reflection configuration. (a) Ewald’s sphere cap at
uency (kz) is only weakly dependent on the backscattering angles or
oded by each wavelength with a small uncertainty as indicated by two
Oz
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Figure 3 Numerical validation of SESF approach: (a) The structure of the simulated 3D object, illuminated along Oz axis; the insert is a
magnified portion of the object. (b) The reconstructed axial spatial-period profile averaged over the entire image area.
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the constructed numerical model (218, 183 and 140 nm),
which confirms the theoretical nanoscale accuracy
of ±10 nm at NA = 0.5.
Experimental setup
The schematic of the SESF system is shown in Figure 4.
This setup is built upon a commercial microscope frame
(AXIO Observer, Carl Zeiss) using reflection configur-
ation at normal illumination. A broadband white-light
source (Xenon-arc lamp 150 W, Newport Inc) was colli-
mated and the backscattered light was collected by the
objective (NA = 0.5). The annular-shaped spatial filter
(SF) was used on Fourier plane (FP) to collect the spec-
tral signals for all accessible scattering and azimuthal an-
gles simultaneously. This SF suppresses the zero-order
signal and removes the contribution of non-informative
zero-order broadband spectrum from each image point,
to provide the required bandwidth of spatial frequencies
and spectral range for spectral encoding of the axial
spatial frequency. On the other hand, the annular
Fourier mask also effectively uses the NA of the optical
system to form a relatively high resolution image. The
SESF and bright-field images were recorded using either
color CCD camera (AxioCam HRc, Carl Zeiss) on the
image plane. Alternatively, a spectral device such as
spectrometer (Acton Research) is also used to obtain the
spectroscopic data on the image plane.IPS
W
L
Figure 4 The schematic of SESF system. S: sample; IP: image plane; FP: FExperimental demonstration using a model system
The ability of SESF system for real-time quantitative
structural imaging of a complex 3D object and nanoscale
sensitivity was demonstrated using nanosphere aggre-
gates of known sizes: 125 ± 3 nm; 147 ± 3 nm; 203 ±
5 nm; 240 ± 5 nm, as illustrated in Figure 5a [21]. The
nanosphere aggregate is formed by a self-assembling
process [21,28,29]. The optical thickness of the nano-
sphere aggregate was ~30 μm, suggesting a multi-layer
structure. Figures 5B-C show the bright-field and corre-
sponding real-time SESF images of nanospheres cap-
tured with a colored CCD camera. The nanosphere size
is well beyond the lateral resolution limit of our optical
system, indistinguishable in conventional bright-field im-
ages, but the axial structural information can pass
through the optical system using SESF. The nanoscale
size differences are clearly presented as distinct colors in
the SESF images. The dominant color in each SESF
image is directly correlated with the dominant spatial
frequency of the axial structure, which depends on
nanosphere size. It should be noted that what we meas-
ure with SESF is the axial spatial period, which is not al-
ways equivalent to the size of the nanosphere aggregate.
As size increases, the axial spatial period increases and
the SESF image shows progressively red-shifted color as
predicted by Eq. (11). The average dominant wave-
lengths (Figure 5d) also show a progressive increase.
Even a 22 nm difference can be distinguished by spectralSpectral device 
(or color camera)
IP
SF
FP
ourier plane; SF: Spatial filter.
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Figure 5 Real-time quantitative structural imaging of nanosphere aggregates using SESF. (a) Illustration of the nanosphere aggregate
configuration. At the image plane of the SESF system, (b) bright-field and (c) SESF images of nanosphere aggregates with four different sizes:
125 nm, 147 nm, 203 nm and 240 nm. (d) The average axial spatial period for the dominant structure of each sample. (e) Distribution of axial
spatial period on the backscattering angle for each sample.
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structural changes.
Depth-resolved spatial-domain low-coherence
quantitative phase microscopy (SL-QPM)
Theoretical basis
Along with assessing the nanoscale structural informa-
tion in K-space, the 3D nanoscale structure of a scatter-
ing object can also be quantified using the quantitative
phase information derived from a modified spectral
interferometry approach. As discussed above, the scat-
tered wave from an inhomogeous weakly scattered ob-
ject can be depicted by the Ewald’s sphere [23,30], and
the 3D spatial frequency, after being scattered from the
scattering object, is given by K = ks – ki.
Compared to other spectral-domain interferometry
setups, the unique aspect of the SL-QPM is that it takes
advantage of the small refractive index mismatch be-
tween the sample and the mounting medium in the clin-
ically prepared biological sample and implicit coherent
gating inherent in the spectral interferometry to detect
the sub-resolution internal structural change in a depth-
resolved manner, rather than the sample thickness differ-
ence (further discussion below).
The SL-QPM uses the standard configuration of clinic-
ally prepared cell or tissue slides to create an interferom-
etry configuration. As shown in Figure 6, for normal
illumination and the collection along the axial z-directionin the reflection configuration, the backscattered waves
are restricted to the axial z-direction, and the spatial fre-
quency reduces to kz = 2kz, where z is the unit vector in
the positive z-direction in K-space. The backscattered
wave from the sample described by Eq. (6) is superim-
posed with the reference wave reflected at the glass-
sample interface, resulting in an interference signal
expressed by [31]
P kð Þ ¼ S kð Þ r2r þ
ZZ
0
r2s z
0
 
dz þ 2
ZZ
0
rs z
0
 
rr cos 2kn z
0
 
z
0
 
dz
0
2
4
3
5
ð14Þ
where S(k) is the power spectrum of the source, rr is
the reflection coefficient of the reference wave, rs(z) is the
scattering coefficient of the sample at depth z, Z is the
total sample thickness and n(z) is the refractive index dis-
tribution along the axial z-direction. The Fourier inverse
of Eq. (14) results in the following equation:
p zopl
  ¼ 2Γ⊗
"
Rr þ Rsð Þδ 0ð Þ þ 2rrℱ −1

ZZ
0
rs z
0
 
cos 2kn z
0
 
z
0
 
dz
0
0
@
1
A# zopl 
ð15Þ
mounting media
sample
reference wave
sample waves
Sample/glass-
slide interface
glass-slide 
coverslip (~170 µm)
spectral 
interference signal
~1 mm
4-5µm
ks
ki kski
z
x, y
Figure 6 The configuration of glass-slide based cell or tissue sample. The reflected wave at the glass-sample interface serves as a reference
wave, and the backscattered wave due to the structural heterogeneity inside the cell serves as a sample wave. The reference wave can also enhanced
by putting a reflection coating at the sample/glass slide interface. The mounting medium is placed between the sample and the coverslip.
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ZZ
0
r2s z
0 
dz) which is a convo-
lution of the source correlation function Γ with the super-
position of the reference wave and the backscattered
sample wave. This mathematical relation suggests that the
source correlation function serves as an implicit coherent
window that separates the phase information at each op-
tical depth whose resolution is limited by the coherence
length. The amplitude of the Fourier-transformed signal
at any given optical depth of interest gives the optical path
length (OPL) distribution along the axial direction of the
sample, while the phase at each fixed optical depth of
interest captures the sub-resolution nanoscale change in
OPL at that location. This sub-resolution change in OPL
is calculated based on Eq. (15),
δp zopl
  ¼ λ0
2π
arctan
Im p zopl
  
Re p zopl
  
 !
ð16Þ
where zopl is the fixed optical depth location, Im and Re
denote the imaginary and real parts of the complex con-
volution p(zopl) respectively, and δp(zopl) is the optical
path length difference (OPD) at a specific optical depth
location zopl, which is not limited by the resolution of
optical system and can be used to probe the nanoscale
structural changes of the biological cell.
SL-QPM instrument
We developed a simple optical microscopy system using
low-coherence white light, referred to as spatial-domain
low-coherence quantitative phase microscopy (SL-QPM),
to implement the above-discussed approach. As shown in
Figure 7, the SL-QPM is that based on a reflection con-
figuration, and the inherent configuration of clinically
prepared biological samples (shown in Figure 6) creates
the common-path interferometry configuration. Suchconfiguration helps eliminating the phase noise in the
conventional interferometry configuration, in which the
reference and sample waves have separate optical paths.
The use of a broadband white light from Xenon-arc lamp
of low-coherence light source helps eliminating the
speckle noise. The reflectance image from the sample was
collected by a scanning imaging spectrograph (Acton Re-
search, MA) and a CCD camera (Andor Technology, CT)
that recorded a three-dimensional spatial-spectral inten-
sity cube I(x, y, k), which is then transformed into an OPD
map δp(x, y, zopl) at a specific zopl based on Eqs. (15-16).
Nanoscale sensitivity
The structural sensitivity, which is defined as the ability
of this system to detect the smallest OPD change, is not
limited by the resolution of light microscopy, but limited
by the system stability. We investigated the temporal sta-
bility of the depth-resolved values at the fixed optical
depth locations of 1.5 μm, 3 μm, 4.5 μm, and 6 μm, re-
spectively. The depth-resolved values are relatively stable
with a mean standard deviation around 1 nm due to
temporal fluctuations, which is 0.76 nm, 0.78 nm,
0.86 nm and 1.2 nm at the optical depth locations of
1.5 μm, 3 μm, 4.5 μm, and 6 μm respectively. This stand-
ard deviation of mean OPD value of ~1 nm determines
the nanoscale sensitivity. Please note that the nanoscale
sensitivity is not nanoscale resolution. It does not dir-
ectly image an object at the nanoscale resolution, but de-
tect the structural changes at the sensitivity of ~ 1 nm.
So the experimental interpretation of OPD value is only
meaningful in the context of comparing the relative
structural changes.
Analysis of SL-QPM internal nanoscale structural changes
Our goal is to use SL-QPM to probe the nanoscale
structural changes associated with the biological pro-
cesses. However, in most spectral interferometry setup,
 SS
TLM1
RM2
CAM
CCD
SP
L1 L2
Xe
A
ST
BS
M3
OB2
M2
RM1
OB1
Figure 7 The schematic of SL-QPM setup. Xe: Xenon lamp; L: lens; OB: objective; M: mirror; RM: removable mirror; TL: tube lens; SP:
spectrograph; SS: scanning stage.
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http://www.biomedcentral.com/2046-1682/7/1the nanoscale change in OPL comes from the structural
changes at a distinct physical interface with a strong
refractive-index mismatch. In most cell or tissue prepar-
ation, the biological cells have a strongest refractive
index mismatch at the interface of cell and mounting
medium. As a result, such measurement often reflects
the surface variation of the cell rather than the internal
structural changes. The cell surface variation is some-
times non-specific and subject to the cell preparation
artifact.
To probe the nanoscale changes in the internal struc-
ture of the cell or tissue, we prepared the biological sam-
ples with a small refractive index mismatch between the
sample and the mounting medium. Thus the sample
wave predominately comes from backscattered waves
from inside the scattering sample, not the reflection
from the sample-mounting medium interface.
Another important property of the SL-QPM system is
its implicit coherent gating inherent in the spectral
interferometry. According to Eq. (15), the Fourier-
transformation of the spectral interference signal is a
convolution of the source correlation function Γ (i.e., the
power spectral density of the source) and the actual
OPL profile of the scattering object. As an example, we
assume the true OPL profile of the scattering object as
the distinct blue stem-plot in Figure 8a. Due to the lim-
ited spectral bandwidth of the light source, the source
correlation function, as indicated in Figure 8a, serves as
a window for coherent gating to restrict the detected
OPD to come from the back-scattered waves within this
window around the given optical-depth of interest, with-
out being affected by the scattered waves from those op-
tical depths at one or more coherence-length apart. Thederived OPL profile from the SL-QPM system is illus-
trated in Figure 8b, where the original OPL profile from
the scattering object is modified by the source correl-
ation function. If multiple fixed optical depth locations
are chosen such that the distance between them is at
least one coherence length apart [indicated by the red
dots in Figure 8a], we can capture the internal structural
changes within the coherence-gated optical section
around each optical depth. The physical conditions for
this approach to be effective include a closely matched
refractive index between the sample and mounting
medium and the signal strength at the selected locations
is above the noise floor.
Validation of SL-QPM to probe internal nanoscale structural
changes
We conducted experiments to validate that SL-QPM in-
deed probes the internal structural changes, rather than
the non-specific surface variation due to the sample
preparation artifact [31]. Our experiment is based on the
hypothesis that if we use the same tissue sample that is
sectioned at the different thickness, the implicit coher-
ence gating should ensure that the detected OPD from
an internal depth location is the same, independent of
the section thickness. We used serial tissue sections of
the small intestinal tissue from a normal mouse sec-
tioned at 4 μm and 5 μm using a microtome, placed on
the coated glass slide, coverslipped with a mounting
medium (n = 1.50), without any staining. As the tissue
sections are serial sections of the same tissue segment, it
is reasonable to assume that these two tissue sections
have similar structural properties, but different thick-
ness. With the SL-QPM instrument and the method
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Figure 8 Illustration of depth-resolved SL-QPM via coherence gating at multiple fixed depth locations (shown as red dots). (a) The
illustration of convolution of source correlation function and the original profile of the scattering object (blue stem-plot). (b) The derived OPL
profile from SL-QPM system.
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http://www.biomedcentral.com/2046-1682/7/1discussed above, we analyzed the spectral interference sig-
nal from a similar tissue area – expressed as a function of
spatial frequency K and then extracted δp(x, y, zopl) at the
optical depth inside the sample (zopl =3 μm), as shown in
Figure 9, clearly supporting that the OPD indeed detect
the internal structural changes, rather than the variation
in sample thickness.Results and discussion
In this section, we will show some examples of using
SESF and SL-QPM based methods to detect nanoscale
structural changes in a fundamental biological process
important in cancer, as well as to demonstrate the ability
to detect pre-cancerous changes in clinical samples be-
yond what conventional light microscopy can detect.0
5
10
15
20
25
30
35
40
(n
m
)
p= 0.91
4µm thick 5µm thick
zopl= 3 µm
Figure 9 The OPD (δp) for 4 μm and 5 μm thick sections at
fixed optical-depth locations at the optical depth of 3 μm. The
OPD remains the same in the similar tissue area, independent of
tissue thickness. The error bar represents the standard error based
on the analysis of approximately 40 cells from the similar area of
two serial sections.Nanoscale structural changes in abnormal cell growth
As cancer is a result of uncontrolled cell growth, under-
standing the nanoscale structural changes in the abnor-
mal cell growth is an important first step in their use to
detect pre-cancerous changes. We performed a proof-
of-concept study to analyze the nanoscale structural
changes in the nuclei of HeLa cells during abnormal mi-
tosis, one of the hallmarks in cancer. We use an estab-
lished cancer cell line, HeLa cell, arrested at two distinct
phases of cell cycle – G1/S and G2/M, as described pre-
viously [32]. We used a drug – thymidine – that inhibits
DNA synthesis to arrest cells at G1/S; and then followed
by nocodazole treatment which disrupts microtubules
required for cell mitosis to prevent cell division and ar-
rest cells at G2/M. As the normal mitosis is inhibited
and the cell does not divide, the DNA that replicated in
the S phase cannot split between two daughter cells,
resulting in doubled DNA content in the cell nucleus
[32]. Further, the TEM images show the presence oflarger chromatin clusters in the nucleus of the cells at
G2/M phase, compared to that of cells at G1/S phase
(Figure 10).
Figure 11 show bright-field and SESF images of cells at
G1/S and G2/M phase, respectively, using an objective
with NA = 0.5. The changes in DNA content or chroma-
tin cluster are not visible in the bright-field images, but
the SESF images show a significantly red-shifted color in
the nucleus of G2/M, which suggests an increased spatial
period corresponding to the presence of larger struc-
tures. To further characterize the detailed spatial-period
profile of cell internal structure, we compared the axial
spatial-period profile of the nuclear structure quantified
by SESF approach, averaged over 10–20 cells, shown in
(b)(a)
Figure 10 The transmission electron microscopy (TEM) images
of cells arrested at (a) G1/S phase and (b) G2/M phase,
respectively. The red arrow indicates the presence of large high-
order chromatin clusters in the nucleus of cells at G2/M phase.
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http://www.biomedcentral.com/2046-1682/7/1Figure 11f, with the spatial-period profile extracted from
TEM images of the cell nuclei via Fourier analysis, aver-
aged over ~10-20 cells, shown in Figure 11e at G1/S and
G2/M phase, respectively [20]. They both suggest a sig-
nificant increase in spatial period for cells in G2/M com-
pared to those in G1/S. Such structural difference is
clearly not detectable in bright-field microscopy.
The structural difference can also be detected by the
OPD changes derived from the SL-QPM system. Figure 12
shows a representative OPD map at the G1/S phase.
Figure 13 shows the averaged OPD difference δp at two
different depths, by statistical analysis of ~90 nuclei at
G1/S and G2/M, respectively. Overall, a significant nano-
scale increase in the average OPD value is seen at both op-
tical depths (3 and 4.5 μm) within cell nuclei at G2/M
compared to those at G1/S [31]. The higher DNA content at
G2/M phase increases the nuclear density and refractive
index, resulting in a higher OPD value. Such nanoscale
change in OPD as a result of the changes in DNA content is
also not easily detectable in conventional microscopy.(a) (b)
(c) (d)
(e) 
Sp
Figure 11 Characterization of structural changes at different cell-cycle
unstained HeLa cells arrested at G1/S and G2/M phases of the cell nuclei. S
period in the colored images of (c) and (d). (e-f) The comparison of spatiaNanoscale structural changes in pre-cancerous cervical cells
To evaluate the structural changes in pre-cancerous
cells, we used SESF to analyze the cervical cytology spec-
imens of 18 patients, among whom 9 diagnosed with
negative intraepithelial lesion or malignancy (NILM, nor-
mal group) and 9 diagnosed with high-grade squamous
intraepithelial lesion (HSIL, high-grade pre-cancerous
group). Figure 14 shows the representative bright-field
(a,c) and corresponding SESF images (b,d) for the un-
stained normal squamous cells from a patient with NILM
and high-grade precancerous cells from a patient with a
HSIL cytology diagnosis. The bright-field images do not
reveal internal nuclear structural difference, except for the
overall size difference. However, the SESF images exhibit a
distinct red-shifted color in the nuclei of high-grade pre-
cancerous cells (Figure 14d), compared to those of normal
cells (Figure 14b) [21]. This color shift suggests an in-
creased spatial period in the axial intra-nuclear structure
of the pre-cancerous cells, according to Eq. (11). The true
color in the SESF image can be quantitatively converted
into dominant wavelength based on the color-vision algo-
rithm [21]. The dominant axial structure within the nuclei
can be further quantified as the axial spatial period (Hz)
derived from dominant wavelength and Eq. (11). The col-
orbar in Figure 14 presents the conversion between each
color and dominant axial spatial period.
As the cell-to-cell variation is often significant, to con-
firm that such color shift in the cell nuclei of pre-
cancerous cells is also statistically significant, we evaluated
~20 cells per patient and then took the average value of
the dominant wavelengths and their corresponding aver-
age dominant axial spatial periods as a representative
value for the patient. As shown in Figure 15, both the
average dominant wavelength and the corresponding axial
spatial period show statistically significant differences
between NILM and HSIL (p-value = 0.006). This resultAxial spatial period Hz, nm
(f) 
atial period, nm
phases using SESF. (a,b) The bright-field and (c,d) SESF images of
cale bar: 10 μm. The color bar shows the corresponding value of spatial
l-period profile extracted from (e) TEM images and (f) SESF images.
(a) (b)
Figure 12 The representative (a) bright-field image and (b) the corresponding OPD map from a cell at G1/S phase.
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http://www.biomedcentral.com/2046-1682/7/1suggests that the internal structures of the high-grade pre-
cancerous cell nuclei exhibit an increased axial spatial
period compared with those in normal cells from the
NILM patients [21]. This proof-of-concept study shows
the potential of SESF to detect structural changes in pre-
cancerous cells not detectable with conventional light
microscopy.
Nanoscale structural changes in breast tissue
We also conducted a proof-of-concept study using
archived breast tissue to investigate how nuclear nano-
architecture changes in breast tumorigenesis with SL-
QPM [33]. We analyzed the OPD values in the cell
nucleus from well-annotated archived histology speci-
mens processed according to standard clinical protocol.
The specimens came from a total of 154 women: 24
healthy patients undergoing reduction mammoplasty; 14
patients with benign lesions; 25 patients with prolifera-
tive lesions (10 without atypia, 15 with atypia without
co-existing IBC); and 32 patients with IBC whose histo-
logically normal cells adjacent to tumor (‘malignant-
adjacent’ normal) were analyzed; and 59 IBC patients
whose malignant cells were analyzed. Among these le-
sions, normal, non-proliferative benign and proliferative(a) 
Figure 13 The depth-resolved changes in OPD (δp) at two fixed optic
at G1/S and G2/M phase. The two-sided p-value is shown on each figure,lesions without atypia are considered as low-risk lesions
(relative risk of 1–1.88 [34]) and patients with these le-
sions are not treated; while proliferative lesions with aty-
pia has a significantly increased risk for breast cancer
(relative risk of 4.24) and patients with this lesion are
typically treated by both surgery and chemopreventive
drug. The malignant-adjacent normal cells are no longer
“normal”, because although these cells appear micro-
scopically “normal” to pathologists, malignant tumor is
already present in adjacent locations. Those malignant
cells present microscopically detectable features charac-
teristic of cancer cells. Therefore, this sequence of nor-
mal to benign, to proliferative without atypia to with
atypia, to malignant-adjacent normal, to malignant cells
represents a progressively increased severity in breast
tumorigenesis.
We first constructed the OPD map at the optical
depth of interest for the cell nuclei and Figure 16 shows
representative pseudo-color OPD maps from cell nuclei
for each of the 6 categories (I to VI in Figure 16). The
color and spatial distribution in these OPD maps reveal
a progressive change from normal through malignant,
which correlates to breast tumorigenesis. The OPD
maps from low-risk lesions (normal, benign, proliferative(b) 
al-depth locations within the nuclei ((a) 3 and (b) 4.5 μm) for cells
calculated from the student t-test.
NILM
HSIL
(a)
(b)
(c)
(d)
Figure 14 Characterization of structural changes in pre-cancerous cervical cells using SESF. The (a,c) bright-field and (b,d) SESF images of
normal squamous epithelial cells (NILM) and high-grade squamous intraepithelial (HSIL) cells. The scale bar is 10 μm.
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http://www.biomedcentral.com/2046-1682/7/1without atypia) show similar pattern, while the high-risk
lesion and malignant lesions are distinctly different.
Most importantly, the OPD maps from malignant-
adjacent “normal” cells, although histologically normal-
appearing, exhibit a great similarity to those of malignant
cells, indicative of cancer-like nano-morphology signa-
tures in these malignant-adjacent “normal” cells.
To quantify the nano-morphology signatures reflected
in these OPD maps, we extracted four quantitative(a)
Figure 15 Statistical analysis of (a) dominant wavelengths and (b) the
normal squamous epithelial cells (NILM) and high-grade squamous in
of the two-sided p-value of student t-test assuming unequal variance.markers from the OPD map of each cell nucleus, includ-
ing average nuclear OPD <OPD>, intra-nuclear standard
deviation of OPD σOPD, entropy EOPD and uniformity
UOPD. Their mean value of 40–60 cell nuclei is used as
the characteristic marker for each patient. As we previ-
ously shown in the cell cycle experiment, the < OPD > is
associated with nuclear density; and intra-nuclear σOPD,
EOPD, and UOPD are different measures of structural het-
erogeneity from each cell nucleus. As shown in Figure 17,(b)
corresponding dominant axial spatial period in the nuclei of
traepithelial (HSIL) cells. The error bar is standard error. The p-value
Figure 16 Representative conventional images of breast biopsies and structure-derived optical pathlength difference (OPD) map from
a single cell nucleus (marked in circles) from (I) normal cells from a healthy patient; (II) cells labeled as fibrocystic changes from a
non-proliferative benign patient; (III) cells labeled as ductal epithelial hyperplasia from a patient with concurrent apocrine metaplasia
and cystic changes; (IV) cells labeled as atypical lobular hyperplasia; (V) cells as “normal” defined by the expert pathologist from a
patient with invasive breast carcinoma (‘malignant-adjacent’ normal); and (VI) cells labeled as “malignant” from a patient with invasive
breast carcinoma. The color bar represents the OPD value from the cell nucleus.
Figure 17 Statistical analysis of nano-morphology markers in annotated breast tissue with different pathology types. The * sign indicates
statistical significance between two groups with two-sided p-value < 0.05.
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http://www.biomedcentral.com/2046-1682/7/1these four nano-morphology markers progressively chan-
ged in parallel with the development of breast tumorigen-
esis. In particular, <OPD > values in low-risk lesions are
similar without statistical significance (ANOVA, P > 0.05).
On the other hand, <OPD > is significantly increased in
high-risk lesion (proliferative with atypia), and such
change in even more elevated in patients with malignancy.
The structural heterogeneity measures (σOPD, EOPD and
UOPD) show a distinct difference between normal and be-
nign lesions, suggesting that they are also sensitive to ab-
normal changes in the breast tissue, even for low-risk
benign conditions. Their values are significantly different
from patients with malignancy. Such nano-morphology
changes cannot be detected by quantitative measure of
microscopic features of the nucleus. For example, the
nuclear size, which is the most important measure in
diagnosing breast cancer, does not show any statistical
significance between normal and patients with malignant-
adjacent normal cells [33]. The only significant change is
seen between malignant cells and the rest of non-
malignant cells (including normal, benign, proliferative le-
sions and ‘malignant-adjacent’ normal cells), in agreement
with conventional pathology.
This proof-of-concept study demonstrates that nuclear
nano-morphology markers, derived from SL-QPM, show
great promise to detect breast cancer with a high accur-
acy beyond conventional pathology. These nuclear nano-
morphology markers are based on the detection of
nanoscale structural characteristics, which otherwise
cannot be appreciated using light microscopy or digital
image analysis.
Conclusions
The analysis of nanoscale structural characteristics has
shown some promise in detecting cancer before the
microscopically visible changes become evident and sev-
eral proof-of-concept studies using clinical patient sam-
ples have also shown its feasibility as an earlier or more
sensitive marker for cancer detection or diagnosis in a
clinical setting. From a basic science perspective, we will
need further understanding and validation to identify
specific 3D nanoscale structural characteristics as a down-
stream manifestation of complex molecular changes in
carcinogenesis via direct super-resolution imaging of the
3D nuclear architecture in carcinogenesis using well-
annotated human tissue from different tumor types. It re-
mains an important biophysical question to be addressed.
For example, what are specific 3D high-order chromatin
structural alterations at the nanoscale in the development
of cancer? How are they affected by molecular heterogen-
eity of the tumor? How do they change as a response to
anti-cancer treatment? Ultimately, the elucidation of spe-
cific nanoscale structural characteristics together with the
development of cost-effective and clinically applicabletools to accurately interrogate these nanoscale structural
features in a high-throughput manner will have a signifi-
cant potential clinical impact in bringing a new class of
cancer markers for “personalized” cancer detection, diag-
nosis, prognosis, or monitoring of drug response or tumor
recurrence.
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